Compile Data Set for Download or QSAR
maximum 50k data
Found 43 with Last Name = 'witowsky' and Initial = 'j'
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080960(2-Bromo-N-[(1S,2S)-3-{[2-(2,4-dichloro-phenyl)-eth...)
Affinity DataIC50:  0.700nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM912((3S,4S)-3-hydroxy-4-[(2S)-2-[(3S,4S)-3-hydroxy-6-m...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedMMDB

TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080973(3,5-Dichloro-2-(3,5-dichloro-2-hydroxy-benzenesulf...)
Affinity DataIC50:  250nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080991(5-[1-[4-(4-Benzoyl-3-hydroxy-2-propyl-phenoxymethy...)
Affinity DataIC50:  340nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080980(3,5-Dichloro-2-hydroxy-benzenesulfonic acid 2,4-di...)
Affinity DataIC50:  460nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080981(3,5-Dichloro-2-hydroxy-benzenesulfonic acid 2,4-di...)
Affinity DataIC50:  490nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080965(3,5-Dichloro-2-(3,5-dichloro-2-hydroxy-benzenesulf...)
Affinity DataIC50:  600nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080972(3,5-Dichloro-2-hydroxy-benzenesulfonic acid 4-chlo...)
Affinity DataIC50:  700nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080970(3,5-Dichloro-2-(3,5-dichloro-benzoylamino)-N-[4-(6...)
Affinity DataIC50:  780nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080969(CHEMBL86182 | N-[4-(Benzothiazol-2-ylsulfanyl)-3-t...)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080955(3,5-Dichloro-N-[4-(6-chloro-benzothiazol-2-ylsulfa...)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080951(CHEMBL86237 | N-[4-(Benzothiazol-2-ylsulfanyl)-2-m...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080979(CHEMBL429357 | N-[4-(Benzothiazol-2-ylsulfanyl)-3,...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080990(1N-[4-(6-ethoxybenzo[d][1,3]thiazol-2-ylsulfanyl)p...)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080984(3,5-Dichloro-N-[4-(6-ethoxy-benzothiazol-2-ylsulfa...)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080982(CHEMBL85111 | N-[4-(Benzothiazol-2-ylsulfanyl)-3-c...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080986(3,5-Dichloro-2-hydroxy-N-[4-(6-trifluoromethoxy-be...)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080985(3,5-Dichloro-N-[4-(5-ethoxy-benzothiazol-2-ylsulfa...)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080961(2-{4-Chloro-2-[4-(6-ethoxy-benzothiazol-2-ylsulfan...)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080974(CHEMBL315139 | N-[4-(Benzothiazol-2-ylsulfanyl)-3-...)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080968(CHEMBL263810 | N-[4-(Benzothiazol-2-ylsulfanyl)-3-...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080959(3,5-Dichloro-2-hydroxy-N-[4-(6-methoxy-benzothiazo...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080963(2-{4-Chloro-2-[4-(6-ethoxy-benzothiazol-2-ylsulfan...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080952(CHEMBL314703 | N-[4-(Benzothiazol-2-ylsulfanyl)-3-...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080989(3-{4-Chloro-2-[4-(6-ethoxy-benzothiazol-2-ylsulfan...)
Affinity DataIC50:  2.20E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080957(CHEMBL85212 | N-[4-(Benzothiazol-2-ylsulfanyl)-2-c...)
Affinity DataIC50:  2.40E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080958(3,5-Dichloro-2-hydroxy-N-[4-(quinolin-2-ylsulfanyl...)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080977(CHEMBL309479 | N-[6-(Benzothiazol-2-ylsulfanyl)-py...)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080964((2-{4-Chloro-2-[4-(6-ethoxy-benzothiazol-2-ylsulfa...)
Affinity DataIC50:  2.70E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080966(CHEMBL315691 | N-[4-(Benzothiazol-2-yloxy)-phenyl]...)
Affinity DataIC50:  2.80E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080967(CHEMBL84561 | N-[4-(Benzothiazol-2-ylsulfanyl)-phe...)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080971(CHEMBL431978 | N-[4-(Benzooxazol-2-ylsulfanyl)-phe...)
Affinity DataIC50:  3.20E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080956(CHEMBL85889 | N-{4-Chloro-2-[4-(6-ethoxy-benzothia...)
Affinity DataIC50:  3.80E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080954(3,5-Dichloro-2-hydroxy-N-[4-(5-methoxy-benzothiazo...)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080978(2-Amino-3,5-dichloro-N-[4-(6-ethoxy-benzothiazol-2...)
Affinity DataIC50:  5.50E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080975(3,5-Dichloro-N-[4-(6-ethoxy-benzothiazol-2-ylsulfa...)
Affinity DataIC50: >7.00E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080976(CHEMBL81996 | N-[4-(Benzooxazol-2-yloxy)-phenyl]-3...)
Affinity DataIC50:  7.20E+3nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080962(5-Chloro-N-[4-(6-ethoxy-benzothiazol-2-ylsulfanyl)...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080992(3-Chloro-N-[4-(6-ethoxy-benzothiazol-2-ylsulfanyl)...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080988(CHEMBL81963 | N-[4-(6-Ethoxy-benzothiazol-2-ylsulf...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080983(CHEMBL311721 | N-[4-(6-Ethoxy-benzothiazol-2-ylsul...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080953(CHEMBL367404 | N-[4-(6-Ethoxy-benzothiazol-2-ylsul...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin D(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50080987(CHEMBL84317 | N-[4-(6-Ethoxy-benzothiazol-2-ylsulf...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed